Past Events

The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.

Award Terms

• The grant amount is $250,000 per year for three (3) years totaling $750,000.
• Indirect costs are not to exceed 10% of direct costs and are included in total.
• Emerging Leader Awards are granted to a single investigator; co-investigators are not permitted. The award may be used to support projects carried out with collaborators, who may provide letters of support.
• In Year 3, at The Mark Foundation’s discretion, select Awardees may be invited to apply for up to two (2) years of additional funding depending on project progress.
• The letter of agreement will include IP terms with a revenue sharing component.
• Award start date will be January 1, 2025.

The portal to submit letters of intent for the upcoming Emerging Leader Award will open on March 20, 2024. Letters of Intent must be submitted through the online application system no later than 5 PM Eastern Time on Monday, April 29, 2024. Learn more about the application process here. 

This panel discussion delves into data rights in AI-related technologies and strategies for successful commercialization. Panelists include Jason Novak of Norton Rose Fulbright, Fernando Gómez-Baquero, Director of the Runway Startup Postdoc and Spinout Programs, and Vince Hartman, Co-founder and CEO of Abstractive Health. This engaging session will offer a multifaceted view on leveraging AI technologies for commercial success, ensuring data rights, and navigating the evolving landscape of AI commercialization. Food and drink networking reception to follow! 

Register here. 

OUP is pleased to invite you to our annual startup financing trends webinar. Join Harry Won, Nii Dodoo-Amoo and Nabil Ullah of OUP’s investment team for a discussion on startup financing trends to review the state of the venture funding landscape.

We’ll cover current market behaviors across the entire startup ecosystem with a specific emphasis on university spinouts. Harry Won will outline trends in the life sciences, including biopharma, research tools, diagnostics, and medical devices while Nii Dodoo-Amoo and Nabil Ullah will review the tech and physical sciences, ranging from software to climate tech.

OUP leverages public sources and its own proprietary database of active university spinouts from its partner institutions to provide unique insights and perspectives for 2024 and beyond. Register here. 

CTL at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell business development and licensing professional.

The March 12th office hours will be hosted by Eric Bryant, Intellectual Property Officer at Weill Cornell Medicine Enterprise Innovation. 

Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Center for Technology Licensing to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. 

Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology. 

Schedule your 30-minute session here.